Effective October 1, 2014, Nexium® will be
removed from the Select Drug Program® Formulary. This change
will move the drug from Tier 2 (formulary level of cost-sharing) to Tier 3
(non-formulary level of cost-sharing). Additionally, Nexium® (40
mg capsules and packets for suspension) will now require prior
authorization.
Generic proton pump inhibitors (PPI), such as lansoprazole, omeprazole,
pantoprazole, and rabeprazole, are available on Tier 1 (the lowest level of
cost-sharing) with no requirement for prior authorization.
Nexium® is also available over-the-counter (OTC), along with
other PPIs such as Prevacid® and Prilosec®.
Please discuss the generic PPI alternatives and the proper use of OTC
products with your patients to determine the most appropriate plan of action.
As a reminder, using the lowest dose possible for the shortest duration will
help to minimize potential long-term adverse effects from these agents. Also,
patients can help to alleviate symptoms by incorporating lifestyle
modifications including, but not limited to:
- weight loss
- smoking cessation
- not overeating
- avoiding acidic foods
To learn more about the PPI alternatives for Nexium® or tips for
an appropriate plan of action, please call Customer Service at
1-800-275-2583 for providers in Pennsylvania and Delaware and at
1-888-YOUR-AH1 (1-888-968-7241) for providers in New
Jersey.